Navigation Links
Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
Date:9/3/2014

so participating in the ongoing efforts by public health authorities, including the Centres for Disease Control and the WHO, to mount a coordinated world response to address the immediate needs raised by the Ebola outbreaks.

About Ebola

The Ebola virus belongs to a virus family called Filoviridae and can cause severe hemorrhagic fever in humans and nonhuman primates.  Ebola has a mortality rate ranging from 50% to 90% according to the World Health Organization.  The virus is highly prioritized by the U.S. Government, who has defined the virus as a "Category A" agent, due to its high mortality rate.  Currently, no licensed vaccine, treatment or cure exists for this disease.

About Johnson & Johnson

Caring for the world one person at a time inspires and unites the people of Johnson & Johnson.  We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 126,000 employees at more than 270 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

About Crucell

Crucell is part of the Janssen Pharmaceutical Companies of Johnson & Johnson, and is focused on research development and production of vaccines, proteins and antibodies that prevent and/or treat infectious diseases.  Crucell is a major supplier of vaccines to UNICEF and the developing world.  Crucell was the first manufacturer to launch a fully-liquid pentavalent vaccine named Quinvaxem®.  With this innovation, Crucell has become a major partner in protecting children in developing countries against major infectious diseases.  Crucell has a broad development pipeline, with several product candidates based on its unique AdVac® and/or PER.C6® production technology.  Crucell licenses its PER.C
'/>"/>

SOURCE Johnson & Johnson
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
2. Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters
3. N.J. Woman Sues Johnson & Johnsons Ethicon Unit Over Vaginal Mesh Injuries, Says The Lanier Law Firm
4. Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results
5. GHX CEO Bruce Johnson Recognized as Ernst & Young Rocky Mountain Region Entrepreneur of the Year 2012
6. Johnson & Johnson Provides Notice Of Proposed Settlement Of Shareholder Derivative Actions, Final Settlement Hearing, And Right To Appear
7. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
8. EFJohnson Announces Impact Partner Dealer Program
9. Johnson Health Tech Statement on Lance Armstrong
10. Robert G. Savage, Former Worldwide Chairman, Johnson & Johnsons Pharmaceuticals Group, Joins Board of Nuovo Biologics, LLC
11. Johnson & Johnson Announces Plans to Establish Innovation Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21, 2015  Inmark,s acquisition of Saf-T-Pak last ... Goods Training, specifically Division 6.2.  For over 25 ... training programs focusing on IATA, ICAO, US DOT, ... "We were particularly interested in Saf-T-Pak,s ... multilingual internet training programs," said David Oyler ...
(Date:4/21/2015)... 21, 2015 Global cap & ... demand for caps and closures will exceed $55 billion in ... two trillion annually. Beverages will continue to account for well ... a number of smaller markets are expected to register faster ... Although the most developed markets -- the US, ...
(Date:4/21/2015)... 21, 2015 The global dermatology diagnostic devices ... 8.2% from 2014 to 2019. North America ... larger shares in the global dermatology diagnostic devices market. ... is mainly attributed to a wide range of factors, ... of dermatologists, and technological advancements made in the field ...
Breaking Medicine Technology:Inmark's Acquisition Of Saf-T-Pak Results In Expansion Of Its Dangerous Goods Training Portfolio 2World Caps & Closures Market 2World Caps & Closures Market 3Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 2Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 3
(Date:4/21/2015)... 21, 2015 The California Healthcare ... leading life sciences organizations, released the following statement ... California State Assembly Bill (AB) 463: , “As ... the development of treatments and cures for patients ... concerns regarding AB 463, the so-called Pharmaceutical Cost ...
(Date:4/21/2015)... City, NJ (PRWEB) April 21, 2015 ... collaboration across platforms and devices, today announced a new ... integration of the new Microsoft Office 365 Management Activity ... allows customers to fully audit and take action on ... environments. , “The new Office 365 Management Activity API ...
(Date:4/21/2015)... 2015 Lowcostcarinsuranceprice.com has released a new blog ... for SUVs. , SUVs are large vehicles that ... an SUV and a smaller regular car shows that passengers ... This makes SUV safer in crashes, but these large vehicles ... situation. , It is now possible to find low ...
(Date:4/21/2015)... 2015 Carinsurancehints.com has released a new ... their impact on auto insurance prices . ... insurance prices. Clients should review their insurance options before ... bought under several forms. Some of the popular policies ... can compare online rates and find the best prices ...
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 Respected ... PACS® strategy , Visage Imaging Inc. (“Visage”), ... PME), has signed a seven-year contract with University ... in Northern Florida. The deal furthers the penetration ... hospital space, a key area of the North American ...
Breaking Medicine News(10 mins):Health News:California Healthcare Institute Statement on AB 463 2Health News:California Healthcare Institute Statement on AB 463 3Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 2Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 3Health News:Auto Insurance Quotes For SUVs Are Available Online 2Health News:Heavily Circulated Roads Can increase Auto Insurance Costs 2Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4
... By Maureen Salamon HealthDay Reporter , WEDNESDAY, ... improve patient safety, a six-year study at 10 North ... which included medical errors and unavoidable mistakes. ... randomly selected hospital admissions, teams of reviewers found 588 ...
... HealthDay Reporter , WEDNESDAY, Nov. 24 (HealthDay ... cancers aren,t diagnosed until the disease is well-advanced and, ... Almost one-half of colorectal cancers and cervical cancers ... are detected at a late stage, according to the ...
... light both the promise and the frustration of developing ... of skin cancer. Early clinical tests of a candidate ... results in patients whose cancers resisted all currently available ... invariably returned a few months later, able to withstand ...
... , WEDNESDAY, Nov. 24 (HealthDay News) -- A study ... lethal for blacks than it is for whites. In ... nearly one-fifth higher than it is for whites in that ... Office on Smoking and Health at the U.S. Centers for ...
... 24 It,s never fun riding the bench but could ... the future? That,s one of the questions being explored by ... Wilfrid Laurier University and the Canada Research Chair in Group Dynamics ... this week,s Canada Research Chairs conference in Toronto. Eys, ...
... London, UK, 24 November 2010 Research from ... ( http://www2.i-med.ac.at/psychlab/ ) at the Medical University Innsbruck ... in rats exhibited pathologies similar to Alzheimer,s disease. ... Neuroscience (45(4):408-417, 2010) with lead author Dr. ...
Cached Medicine News:Health News:Despite Efforts, Study Finds No Decline in Medical Errors 2Health News:Despite Efforts, Study Finds No Decline in Medical Errors 3Health News:Too Many Cancers Still Spotted Too Late: CDC 2Health News:Too Many Cancers Still Spotted Too Late: CDC 3Health News:Researchers shine light on how some melanoma tumors evade drug treatment 2Health News:Researchers shine light on how some melanoma tumors evade drug treatment 3Health News:Black Smokers May Face Higher Death Risk Than Whites: CDC 2Health News:Being a 'good sport' can be critical to maintaining lifelong physical activity 2Health News:Chronic high cholesterol diet produces brain damage 2
Lyphochek Hemostasis Control is a multi-analyte control to help monitor coagulation factor assays and selected thrombosis risk assays. Assayed values are available for most major instrumentation....
... Liquichek Qualitative Urine Toxicology Control is a ... rapid urine drug screen panels, including Point ... test kits like Bio-Rad TOX/See, Biosite Triage ... qualitative results (+/) for popular kits and ...
Liquichek Reticulocyte Control is a human whole blood based control designed to monitor manual and automated methods for counting reticulocytes. Assayed values are provided at three clinically signif...
Liquichek Hematology Control (C) is an assayed hematology control for evaluating the performance of Coulter hematology instruments with complete CBC and VCS 5-part differential technology....
Medicine Products: